Proteovant Therapeutics
Corey has 25+ years in building structural biology drug discovery platforms across multiple disease areas. Previously Senior Principal Scientist at Merck.
This person is not in any offices
Proteovant Therapeutics
Proteovant Therapeutics is a biotechnology company that utilizes protein degradation research in the development of medicines for diseases.